Agnese Cattaneo

712 total citations
43 papers, 487 citations indexed

About

Agnese Cattaneo is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, Agnese Cattaneo has authored 43 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Psychiatry and Mental health. Recurrent topics in Agnese Cattaneo's work include Treatment of Major Depression (8 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Renal cell carcinoma treatment (4 papers). Agnese Cattaneo is often cited by papers focused on Treatment of Major Depression (8 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Renal cell carcinoma treatment (4 papers). Agnese Cattaneo collaborates with scholars based in Italy, Germany and France. Agnese Cattaneo's co-authors include Cinzia Ballabio, Patrizia Restani, Alessandro Fiocchi, Luigi Terracciano, Alessandro Comandini, Francesco Cavagnini, Francesca Pecori Giraldi, Massimo Scacchi, C. Galli and Roberto Biffi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Agnese Cattaneo

41 papers receiving 468 citations

Peers

Agnese Cattaneo
Dong-Jin Park South Korea
C W Lam Hong Kong
Recep Eröz Türkiye
S. P. Peters United States
A Rosztóczy Hungary
Marilyn D. Farber United States
Agnese Cattaneo
Citations per year, relative to Agnese Cattaneo Agnese Cattaneo (= 1×) peers Cahide Yılmaz

Countries citing papers authored by Agnese Cattaneo

Since Specialization
Citations

This map shows the geographic impact of Agnese Cattaneo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnese Cattaneo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnese Cattaneo more than expected).

Fields of papers citing papers by Agnese Cattaneo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnese Cattaneo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnese Cattaneo. The network helps show where Agnese Cattaneo may publish in the future.

Co-authorship network of co-authors of Agnese Cattaneo

This figure shows the co-authorship network connecting the top 25 collaborators of Agnese Cattaneo. A scholar is included among the top collaborators of Agnese Cattaneo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnese Cattaneo. Agnese Cattaneo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sani, Gabriele, William R. Lenderking, Mary Kay Margolis, et al.. (2024). Impact of trazodone once‐a‐day on quality of life and functional recovery in adults with major depressive disorder: A prospective, observational study. Brain and Behavior. 14(7). e3580–e3580. 2 indexed citations
3.
Morata, Laura, Marco Falcone, Juan Pasquau Liaño, et al.. (2024). Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study. Journal of Global Antimicrobial Resistance. 36. 200–209. 2 indexed citations
4.
5.
Leach, John Paul, et al.. (2023). Characterising people with focal drug-resistant epilepsy: A retrospective cohort study. Epilepsy & Behavior. 149. 109540–109540. 2 indexed citations
6.
Čermák, Jan, et al.. (2023). An Observational Pilot Study using a Digital Phenotyping Approach in Patients with Major Depressive Disorder Treated with Trazodone. Frontiers in Psychiatry. 14. 1127511–1127511. 1 indexed citations
7.
Cubała, Wiesław Jerzy, et al.. (2023). Long-Term Treatment with Trazodone Once-A-Day (TzOAD) in Patients with MDD: An Observational, Prospective Study. Neuropsychiatric Disease and Treatment. Volume 19. 1181–1193. 5 indexed citations
8.
Roca, Miquel, Agnese Cattaneo, Alessandro Comandini, et al.. (2022). Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain. International Journal of Psychiatry in Clinical Practice. 27(1). 59–68. 1 indexed citations
9.
Comandini, Alessandro, Agnese Cattaneo, Kathryn Anastassopoulos, et al.. (2022). Real-World Characteristics and Treatment Patterns of Patients With Insomnia Prescribed Trazodone in the United States. Clinical Therapeutics. 44(8). 1093–1105. 8 indexed citations
10.
Kasper, Siegfried, Agnese Cattaneo, Alessandro Comandini, et al.. (2021). Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany. International Journal of Psychiatry in Clinical Practice. 25(4). 393–402. 2 indexed citations
11.
Comandini, Alessandro, et al.. (2021). Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia. International Journal of General Medicine. Volume 14. 4081–4094. 10 indexed citations
12.
Fagiolini, Andrea, Umberto Albert, Laura Ferrando, et al.. (2020). A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder. International Clinical Psychopharmacology. 35(3). 137–146. 27 indexed citations
14.
Almeida, Susana, Agnese Cattaneo, Alessandro Comandini, et al.. (2020). Management and Treatment of Patients With Major Depressive Disorder and Chronic Diseases: A Multidisciplinary Approach. Frontiers in Psychology. 11. 542444–542444. 24 indexed citations
15.
Scacchi, Massimo, Federica Orsini, Agnese Cattaneo, et al.. (2010). The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis. European Journal of Endocrinology. 163(2). 201–206. 14 indexed citations
16.
Scacchi, Massimo, Leila Danesi, Agnese Cattaneo, et al.. (2009). The pituitary–adrenal axis in adult thalassaemic patients. European Journal of Endocrinology. 162(1). 43–48. 22 indexed citations
17.
Scacchi, Massimo, Leila Danesi, Agnese Cattaneo, et al.. (2008). Bone demineralization in adult thalassaemic patients: contribution of GH and IGF‐I at different skeletal sites. Clinical Endocrinology. 69(2). 202–207. 39 indexed citations
18.
Scacchi, Massimo, Leila Danesi, Agnese Cattaneo, et al.. (2007). Growth hormone deficiency (GHD) in adult thalassaemic patients. Clinical Endocrinology. 67(5). 790–795. 26 indexed citations
19.
Cattaneo, Agnese, Cinzia Ballabio, A Bertelli, et al.. (2003). Evaluation of residual immunoreactivity in red and white wines clarified with gluten or gluten derivatives.. PubMed. 25(2). 57–64. 5 indexed citations
20.
Ruberti, Francesca, et al.. (1995). Monoclonal antibodies to NGF affect learning of radial maze in adult rats. The Society for Neuroscience Abstracts. 21. 548. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026